Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.
Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org
Medicine name : Omcazio
Generic name : Cabozantinib laurylsulfate salt
Manufactured By : Handa Oncology, LLC (Handa Pharmaceuticals)
Indications : Advanced RCC; 1L advanced RCC with nivolumab; HCC after sorafenib; previously treated epNET (age 12+).
Medicine Description : A targeted therapy for advanced renal cell carcinoma (RCC), hepatocellular carcinoma (HCC) after prior sorafenib treatment, and previously treated extra-pancreatic neuroendocrine tumors (epNET) in patients aged 12 years and older. Omcazio (Cabozantinib laurylsulfate salt) is a tyrosine kinase inhibitor that targets multiple receptors involved in cancer cell growth, tumor development and angiogenesis. It is also indicated in combination with nivolumab for eligible patients with first-line advanced renal cell carcinoma.
Omcazio (Cabozantinib Laurylsulfate) is a targeted anticancer medicine used to treat advanced kidney cancer, liver cancer previously treated with sorafenib, and certain previously treated extra-pancreatic neuroendocrine tumors.
Omcazio works by blocking proteins such as MET and VEGFR that are involved in cancer-cell growth and blood vessel formation, helping slow tumor progression.
Omcazio is prescribed for eligible adults with advanced kidney or liver cancer and adults and children aged 12 years and older with certain advanced extra-pancreatic neuroendocrine tumors.
Omcazio is taken orally once daily, with or without food, as prescribed by your doctor. Swallow the capsules whole with water without opening, crushing, or chewing them.
Common side effects of Omcazio include diarrhea, fatigue, decreased appetite, high blood pressure, nausea, vomiting, weight loss, constipation and hand-foot skin reactions.
Omcazio may cause serious side effects such as severe bleeding, blood clots, gastrointestinal perforation, liver problems, heart complications and high blood pressure. Contact your doctor immediately if you experience serious symptoms.
The duration of Omcazio treatment depends on your response to the medicine and how well you tolerate it. Your doctor will decide how long treatment should continue.
Consult your doctor before consuming alcohol during Omcazio treatment, as alcohol may worsen certain side effects.
Omcazio may harm an unborn baby and should not be used during pregnancy. Effective contraception is recommended during treatment and for 4 months after the last dose.
Omcazio may interact with certain medicines, including strong CYP3A inhibitors and inducers. Inform your doctor about all medicines and supplements you take.
If you miss a dose, take it as soon as possible unless it is less than 12 hours before your next dose. Skip the missed dose if fewer than 12 hours remain. Never take a double dose.
Omcazio can be taken with or without food. Swallow the capsules whole with water.
Inform your doctor about existing medical conditions and all medicines you take. Attend regular blood tests and blood pressure checks during treatment.
Store Omcazio at 20°C to 25°C. Permitted temperature excursions are between 15°C and 30°C. Keep it out of reach of children.
Omcazio is a prescription medicine available through authorized pharmaceutical suppliers. Pharma Five may assist patients with access and applicable personal import procedures. Pharma Five assists in its procurement.